UPC Analytics
ENDE
Overview · Filed: —

ORD_22456/2025

FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Procedural & sub-applicationsDefault JudgmentsMilan CDDecision By Default—
OverviewDecisionsCitationsDocumentsTimeline
  • 2025-05-28Infringeddefault_judgmentDecision By Default

    Decision by Milan Central Division (UPC_CFI_597/2024, 22 July 2025) on EOFLOW's revocation action and Insulet's counterclaim for infringement of EP 4 201 327 (wearable insulin pump / patch pump). The court rejected EOFLOW's revocation action (patent upheld as valid) and found EOFLOW's EOPatch product infringed the patent. The court ordered an injunction across 16 UPC member states, product recall, removal from distribution channels, destruction, and full information obligations. The decision also addressed the decision-by-default procedure, patent lexicon interpretation, and the cap on recoverable costs in parallel proceedings.

    Damages: Liability declared, amount deferred